Triputra Aman Makmur is primarily engaged in pharmaceuticals activity. Its headquarters is located in Jawa Timur. The company was founded in 2010. Triputra Aman Makmur was founded by a group of visionary entrepreneurs with a mission to improve healthcare accessibility and quality in Indonesia. The company focuses on the production and distribution of a wide range of pharmaceutical products, including generic medicines, over-the-counter drugs, and specialized healthcare solutions. As a key player in the Indonesian pharmaceutical industry, Triputra Aman Makmur operates several branches across the country, ensuring a strong local presence and efficient distribution network. The company is committed to expanding its reach and currently exports its products to several Southeast Asian countries, contributing to the region's healthcare sector. Triputra Aman Makmur has established strategic partnerships with leading international pharmaceutical companies to enhance its product offerings and leverage advanced technologies. The company is a member of various industry associations, which helps it stay updated with global pharmaceutical trends and regulatory standards. The company is dedicated to research and development, investing in innovative solutions to address emerging healthcare challenges. Triputra Aman Makmur's corporate structure includes several subsidiaries that focus on different aspects of the pharmaceutical supply chain, from manufacturing to distribution. With a vision to become a leading pharmaceutical company in Asia, Triputra Aman Makmur is committed to delivering high-quality, affordable healthcare products. The company's mission is to enhance the well-being of communities by providing innovative and accessible healthcare solutions.
Headquarters
RT 008 RW 002
Mojokerto; East Java;
Postal Code: 61351
Contact Details: Purchase the Pt Triputra Aman Makmur report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service